Cargando…

Amyloid inhibition by molecular chaperones in vitro can be translated to Alzheimer's pathology in vivo

Molecular chaperones are important components in the cellular quality-control machinery and increasing evidence points to potential new roles for them as suppressors of amyloid formation in neurodegenerative diseases, such as Alzheimer's disease. Approaches to treat Alzheimer's disease hav...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abelein, Axel, Johansson, Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	RSC 2023
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10211315/ https://www.ncbi.nlm.nih.gov/pubmed/37252101 http://dx.doi.org/10.1039/d3md00040k

Ejemplares similares

Molecular Mechanisms of Amyloid-β Self-Assembly Seeded by In Vivo-Derived Fibrils and Inhibitory Effects of the BRICHOS Chaperone
por: Kumar, Rakesh, et al.
Publicado: (2023)

Augmentation of Bri2 molecular chaperone activity against amyloid-β reduces neurotoxicity in mouse hippocampus in vitro
por: Chen, Gefei, et al.
Publicado: (2020)

A new kid in the folding funnel: Molecular chaperone activities of the BRICHOS domain
por: Leppert, Axel, et al.
Publicado: (2023)

Metal Binding of Alzheimer’s Amyloid-β and Its Effect on Peptide Self-Assembly
por: Abelein, Axel
Publicado: (2023)

Smallest Secondary Nucleation Competent Aβ Aggregates Probed by an ATP-Independent Molecular Chaperone Domain
por: Leppert, Axel, et al.
Publicado: (2021)

Molecular Structure of Cu(II)-Bound Amyloid-β Monomer Implicated in Inhibition of Peptide Self-Assembly in Alzheimer’s Disease
por: Abelein, Axel, et al.
Publicado: (2022)

Short hydrophobic loop motifs in BRICHOS domains determine chaperone activity against amorphous protein aggregation but not against amyloid formation
por: Chen, Gefei, et al.
Publicado: (2023)

Amyloid Fibril Formation of Arctic Amyloid-β 1–42 Peptide is Efficiently Inhibited by the BRICHOS Domain
por: Zhong, Xueying, et al.
Publicado: (2022)

Chaperones mainly suppress primary nucleation during formation of functional amyloid required for bacterial biofilm formation
por: Nagaraj, Madhu, et al.
Publicado: (2021)

Functionalization of amyloid fibrils via the Bri2 BRICHOS domain
por: Biverstål, Henrik, et al.
Publicado: (2020)

Lysine-targeting inhibition of amyloid β oligomerization by a green perilla-derived metastable chalcone in vitro and in vivo
por: Murakami, Kazuma, et al.
Publicado: (2022)

Fullerenemalonates inhibit amyloid beta aggregation, in vitro and in silico evaluation
por: Melchor, Martínez-Herrera, et al.
Publicado: (2018)

Recombinant Bri3 BRICHOS domain is a molecular chaperone with effect against amyloid formation and non-fibrillar protein aggregation
por: Poska, Helen, et al.
Publicado: (2020)

Amyloid Disassembly: What Can We Learn from Chaperones?
por: Almeida, Zaida L., et al.
Publicado: (2022)

Bri2 BRICHOS client specificity and chaperone activity are governed by assembly state
por: Chen, Gefei, et al.
Publicado: (2017)

Amyloid pathology arrangements in Alzheimer’s disease brains modulate in vivo seeding capability
por: Duran-Aniotz, Claudia, et al.
Publicado: (2021)

Kinetic analysis reveals the diversity of microscopic mechanisms through which molecular chaperones suppress amyloid formation
por: Arosio, Paolo, et al.
Publicado: (2016)

The mouse nicotinamide mononucleotide adenylyltransferase chaperones diverse pathological amyloid client proteins
por: Huang, Chengan, et al.
Publicado: (2022)

Neuroserpin and transthyretin are extracellular chaperones that preferentially inhibit amyloid formation
por: West, Jennifer, et al.
Publicado: (2021)

Advanced nanomaterials for modulating Alzheimer's related amyloid aggregation
por: Shao, Xu, et al.
Publicado: (2022)

Amyloid β and Alzheimer’s Disease: Molecular Updates from Physiology to Pathology
por: Giuffrida, Maria Laura
Publicado: (2023)

A Maitake (Grifola frondosa) polysaccharide ameliorates Alzheimer's disease-like pathology and cognitive impairments by enhancing microglial amyloid-β clearance
por: Bai, Yao, et al.
Publicado: (2019)

Abilities of the BRICHOS domain to prevent neurotoxicity and fibril formation are dependent on a highly conserved Asp residue
por: Chen, Gefei, et al.
Publicado: (2022)

A rationally designed small molecule for identifying an in vivo link between metal–amyloid-β complexes and the pathogenesis of Alzheimer's disease
por: Beck, Michael W., et al.
Publicado: (2015)

Peptidomimetics prepared by tail-to-side chain one component peptide stapling inhibit Alzheimer's amyloid-β fibrillogenesis
por: Kalita, Sujan, et al.
Publicado: (2020)

Biophysical approaches for the study of interactions between molecular chaperones and protein aggregates
por: Wright, Maya A., et al.
Publicado: (2015)

Heat Shock Proteins and Amateur Chaperones in Amyloid-Beta Accumulation and Clearance in Alzheimer’s Disease
por: Wilhelmus, Micha M. M., et al.
Publicado: (2007)

Preventing β-amyloid fibrillization and deposition: β-sheet breakers and pathological chaperone inhibitors
por: Wisniewski, Thomas, et al.
Publicado: (2008)

The anti-Alzheimer potential of Tamarindus indica: an in vivo investigation supported by in vitro and in silico approaches
por: Elmaidomy, Abeer H., et al.
Publicado: (2022)

The Human NUP58 Nucleoporin Can Form Amyloids In Vitro and In Vivo
por: Danilov, Lavrentii G., et al.
Publicado: (2021)

Possible Function of Molecular Chaperones in Diseases Caused by Propagating Amyloid Aggregates
por: Lazarev, Vladimir F., et al.
Publicado: (2017)

Novel caged luciferin derivatives can prolong bioluminescence imaging in vitro and in vivo
por: Zhang, Chaochao, et al.
Publicado: (2018)

ATP‐independent molecular chaperone activity generated under reducing conditions
por: Leppert, Axel, et al.
Publicado: (2022)

The chaperone domain BRICHOS prevents CNS toxicity of amyloid-β peptide in Drosophila melanogaster
por: Hermansson, Erik, et al.
Publicado: (2014)

Decoding Conformational Imprint of Convoluted Molecular Interactions Between Prenylflavonoids and Aggregated Amyloid-Beta42 Peptide Causing Alzheimer’s Disease
por: Srinivasan, E., et al.
Publicado: (2021)

Myelin Pathology: Involvement of Molecular Chaperones and the Promise of Chaperonotherapy
por: Scalia, Federica, et al.
Publicado: (2019)

Molecular Chaperone BRICHOS Inhibits CADASIL-Mutated NOTCH3 Aggregation In Vitro
por: Oliveira, Daniel V., et al.
Publicado: (2022)

Controlled hierarchical self-assembly of networked coordination nanocapsules via the use of molecular chaperones
por: Hu, Xiangquan, et al.
Publicado: (2020)

Natural products triptolide, celastrol, and withaferin A inhibit the chaperone activity of peroxiredoxin I
por: Zhao, Qian, et al.
Publicado: (2015)

Molecular mechanisms of amyloid formation in living systems
por: Sinnige, Tessa
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o7cqep584m2vu9694med9gbvmf